Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Christine Mary Hallinan, Senior Research Fellow, Department of General Practice and Primary Care, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne

How ‘people power’ and business transformed medicine, but created a whole new set of risks

PeterPencil/Getty

There’s been a shift in how some medicines and therapeutic products are accessed and used.

Medicinal cannabis, glucagon-like peptide-1 (GLP-1) weight-loss medicines, ketamine, psychedelics, testosterone and peptides illustrate this shift.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.